臨床整形外科54巻3号

2019年03月発行

誌上シンポジウム サルコペニアと整形外科

整形外科からみたサルコペニアの臨床的病態

著者： 酒井義人¹ 渡邉剛¹ 若尾典充¹ 松井寛樹¹ 富田桂介¹ 飯田浩貴¹

所属機関： ¹国立長寿医療研究センター整形外科

ページ範囲：P.241 - P.247

　サルコペニアは老年内科医を中心として提唱された概念であり，その診断基準には骨格筋量のほかに筋力，歩行速度を考慮することが求められている．一方，われわれ整形外科医において加齢により骨格筋が減少することは，高齢者の日常生活に多大な影響を及ぼすことは十分理解する必要があり，近年，整形外科疾患やその治療成績とサルコペニアの関連についての報告も散見される．整形外科診療におけるサルコペニアの意義を考え，自験例を提示しながら問題点と今後の展望について提言したい．

参考文献

1) Rosenberg IW. Epidermiologic and methodologic problems in determining nutritional status of older persons. Am J Clin Nutr 1989;50(Suppl):1231-3.

2) Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia:European consensus on definition and diagnosis:Report of the European Working Group on Sarcopenia in Older People (EWGSOP). Age Aging 2010;39(4):412-23.

3) Chen LK, Liu LK, Woo J, et al.Sarcopenia in Asia:Consensus Report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014;15(2):95-101.

4) Cruz-Jentoft AJ, Morley JE(ed). Sarcopenia. Chapter 2. Definitions of sarcopenia. Wiley-Blackwell;2012. p.8-19.

5) Inoue W, Ikezoe T, Tsuboyama T, et al. Are there different factors affecting walking speed and gait cycle variability between men and women in community-dwelling older adults? Aging Clin Exp Res 2017;29(2):215-21.

6) Quiben MU, Hazuda HP. Factors contributing to 50-ft walking speed and observed ethnic differences in older community-dwelling Mexican Americans and European Americans. Phys Ther 2015;95(6):871-83.

7) Tiainen KM, Perola M, Kovanen VM, et al:Genetics of maximal walking speed and skeletal muscle characteristics in older women. Twin Res Hum Genet 2008;11(3):321-34.

8) Gillain S, Dramé M, Lekeu F, et al. Gait speed or gait variability, which one to use as a marker of risk to develop Alzheimer disease? A pilot study. Aging Clin Exp Res 2016;28(2):249-55.

9) Hall WJ. Update in geriatrics. Ann Intern Med 2006;145(7):538-43.

10) Shaw AC, Goldstein DR, Montgomery RR. Age-dependent dysregulation of innate immunity. Nat Rev Immunol 2013;13(12):875-87.

11) Hida T, Ishiguro N, Shimokata H, et al. High prevalence of sarcopenia and reduced leg muscle mass in Japanese patients immediately after a hip fracture. Geriatr Gerontol Int 2013;13(2):413-20.

12) Iida H, Sakai Y, Watanabe T, et al. Sarcopenia affects conservative treatment of osteoporotic vertebral fracture. Osteoporosis Sarcopenia 2018;4(3);114-7.

13) Sakai Y, Matsui H, Ito S, et al. Sarcopenia in elderly patients with chronic low back pain. Osteoporosis Sarcopenia 2017;3(4), 195-200.

14) Ji HM, Han J, Jin DS, et al. Sarcopenia and sarcopenic obesity in patients undergoing orthopedic surgery. Clin Orthop Surg 2016;8(2):194-202.

15) Bokshan SL, Han AL, DePasse M, et al. Effect of sarcopenia on postoperative morbidity and mortality after thoracolumbar spine surgery. Orthopedics 2016;39(6):e1159-64.

16) Eguchi Y, Suzuki M, Yamanaka H, et al. Influence of skeletal muscle mass and spinal alignment on surgical outcomes for lumbar spinal stenosis. Asian Spine J 2018;12(3):556-62.

17) Moskven E, Bourassa-Moreau É, Charest-Morin R, et al. The impact of frailty and sarcopenia on postoperative outcomes in adult spine surgery. A systematic review of the literature. Spine J 2018;18(12):2354-69.

18) Koshimizu H, Sakai Y, Harada A, et al. The impact of sarcopenia on cervical spine sagittal alignment after cervical laminoplasty. Clin Spine Surg 2018;31(7), E342-346.

19) Gakhar H, Dhillon A, Blackwell J, et al:Study investigating the role of skeletal muscle mass estimation in metastatic spinal cord compression. Eur spine J 2015;24(10):2150-5.

20) Newman AB, Kupelian V, Visser M, et al:Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci 2006;61(1):72-7.

21) Gale CR, Martyn CN, Cooper C, et al. Grip strength, body composition, and mortality. Int J Epidemiol 2007;36(1):228-35.

22) Visser M, Deeg DJ, Lips P, et al. Skeletal muscle mass and muscle strength in relation to lower-extremity performance in older men and women. J Am Geriatr Soc 2000;48(4):381-86.

23) Visser M, Goodpaster BH, Kritchevskiy SB, et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors off incident mobility limitations in well-functioning older persons. J Gerontol A Biol Sci Med Sci 2005;60(3):324-33.

24) Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults:The health, aging and body composition study. J Gerontol A Biol Sci Med Sci 2006;61(10):1059-64.

25) Hairi NN, Cumming RG, Naganathan V, et al. Loss of muscle strength, mass (sarcopenia), and quality (specific force) and its relationship with functional limitation and physical disability:The Concord Health and Aging in Men Project. J Am Geriatr Soc 2010;58(11):2055-62.

26) Janssen I, Baumgartner RN, Ross R, et al. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004;159(4):413-21.

27) Morley JE. Frailty and sarcopenia:The new geriatric giants. Rev Invest Clin 2016;68(2):59-67.

28) Rolland Y, Lauwers-Cances V, Cristini C, et al. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women:The EPI-DOS (EPIDemiologie de I'OSteoporose) study. Am J Clin Nutr 2009;89(6):1895-900.

29) Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. JAMA 2011;305(1):50-8.

30) Moritani T, deVries HA. Neural factors versus hypertrophy in the time course of muscle strength gain. Am J Phys Med 1979;58(3):115-30.

31) Delmonico MJ, Harris TB, Visser M, et al. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr 2009;90(6):1579-85.

32) Gandevia SC. Spinal and supraspinal factors in human muscle fatigue. Physiol Rev 2001;81(4):1725-89.

33) Clark BC, Taylor JL. Age-related changes in motor cortical properties and voluntary activation of skeletal muscle. Curr Aging Sci 2011;4(3):192-9.

34) Manini TM, Clark BC. Dynapenia and aging:An update. J Gerontol A Biol Sci Med Sci 2012;67(1):28-40.

35) McLean RR, Kiel DP. Developing consensus criteria for sarcopenia:An Update. J Bone Miner Res 2015;30(4):588-92.

36) Kawakami Y, Akima H, Kubo K, et al. Changes in muscle size, architecture, and neural activation after 20 days of bed rest with and without resistance exercise. Eur J Appl Physiol 2001;84(1-2):7-12.

37) Papadakis MA, Grady D, Black D, et al. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med 1996;124(8):708-16.

38) Snyder PJ, Peachey H, Berlin JA, et al. Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 2000;85(8):2670-7.

39) Verbrugge LM, Jette AM. The disablement process. Soc Sci Med 1994;38(1):1-14.